Centennial Wealth Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
+224
New +$229K 0.06% 159
2026
Q1
Sell
-558
Closed -$600K 177
2025
Q4
$600K Buy
558
+192
+52% +$184K 0.16% 88
2025
Q3
$279K Buy
366
+17
+5% +$12.7K 0.08% 138
2025
Q2
$274K Buy
349
+31
+10% +$24.1K 0.09% 133
2025
Q1
$263K Buy
318
+19
+6% +$15.8K 0.1% 128
2024
Q4
$231K Sell
299
-2
-0.7% -$1.66K 0.09% 132
2024
Q3
$267K Buy
+301
New +$271K 0.1% 124

Other funds holding LLY

Centennial Wealth Advisory's LLY Position: Q2 2026 in Review

Centennial Wealth Advisory opened a new position in Eli Lilly (LLY) in Q2 2026: 224 shares worth $269K. The stake represents 0.06% of the portfolio and ranks #159 among its holdings. This is a return to the name: Centennial Wealth Advisory previously reported a position in LLY as recently as Q4 2025.

Centennial Wealth Advisory first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $600K in Q4 2025. 852 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Centennial Wealth Advisory held 224 shares of Eli Lilly worth $269K as of Q2 2026.
  • Eli Lilly was a new Centennial Wealth Advisory position in Q2 2026.
  • Eli Lilly made up 0.06% of Centennial Wealth Advisory's portfolio in Q2 2026, its #159 holding.
  • Centennial Wealth Advisory first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Centennial Wealth Advisory's Eli Lilly position peaked at $600K in Q4 2025.
  • 852 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.